The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
Open accessAbstract
This retrospective cohort study is to investigate the association between herpes simplex virus (HSV) infections and dementia, and the effects of anti-herpetic medications on the risk involved, using Taiwan's National Health Insurance Research Database (NHIRD). We enrolled a total of 33,448 subjects, and identified 8362 with newly diagnosed HSV infections and 25,086 randomly selected sex- and age-matched controls without HSV infections in a ratio of 1:3, selected from January 1, to December 31, 2000. A multivariable Cox proportional hazards regression model was used to evaluate the risk of developing dementia in the HSV cohort. This analysis revealed an adjusted hazard ratio of 2.564 (95% CI: 2.351-2.795, P < 0.001) for the development of dementia in the HSV-infected cohort relative to the non-HSV cohort. Thus, patients with HSV infections may have a 2.56-fold increased risk of developing dementia. A risk reduction of dementia development in patients affected by HSV infections was found upon treatment with anti-herpetic medications (adjusted HR = 0.092 [95% CI 0.079-0.108], P < 0.001). The usage of anti-herpetic medications in the treatment of HSV infections was associated with a decreased risk of dementia. These findings could be a signal to clinicians caring for patients with HSV infections. Further research is, therefore, necessary to explore the underlying mechanism(s) of these associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“HSV-2 seropositivity has also been associated with decreased memory performance, but appeared to be unrelated to global cognition and other cognitive domains, or the risk of all-cause dementia, AD, vascular dementia and other dementias [27,28].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“This risk was nearly eliminated in patients that received antiherpetic treatment (Tzeng et al., 2018).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Tzeng et al., 2018
In the citing paper
“One study demonstrated a significantly increased risk of developing all-cause dementia (~3-fold increase) in patients greater than 50 years of age following a new HSV infection.”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Tzeng et al., 2018
In the citing paper
“The advent of acyclovir, in the late 1980s, considerably modified the prognosis of HSV-1 encephalitis [54–56].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [56]
In the citing paper
“Previous research has found that the development of anti-herpes medications had a positive impact, reducing the incidence of AD [56].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 60
RetractedCharlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Epidemiology of Alzheimer DiseasePreprint
Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,127
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W., Shang, D., Wilcock, G. K., Faragher, B. E., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 671
Gupta, R., Warren, T. J., & Wald, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61908-4 · Cited by 595
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532
Research works printed but not linked: 3
- Tzeng, 2017, The Impact of Pharmacological Treatments on Cognitive Function and Severity of Behavioral Symptoms in Geriatric Elder Patients with Dementia: Pharmacological Treatments on in Elder Patients with Dementia, Taiwanese J Psychiatry., 311, 69
- Daulatzai, 2016, Fundamental Role of Pan-Inflammation and Oxidative-Nitrosative Pathways in Neuropathogenesis of Alzheimer's Disease, Am J Neurodegener Dis., 51, 1
- Kamboh, 1995, Polymorphism and Susceptibility to Alzheimer's Disease, Hum Biol., 672, 195
Cited by
Sorted by citations
Items 101–200 of 368
Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
Lathe, R., & Clair, D. S. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12959 · Cited by 37
Dementia, infections and vaccines: 30 years of controversy
Ecarnot, F., Boccardi, V., Calcagno, A., Franceschi, C., Fülöp, T., Itzhaki, R. F., Michel, J., Panza, F., Rainero, I., Solfrizzi, V., et al. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02409-8 · Cited by 34
Pretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36
Mullane, K., & Williams, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.027 · Cited by 32
Elhalag, R. H., Motawea, K. R., Talat, N. E., Rouzan, S. S., Reyad, S. M., Elsayed, S. M., Chèbl, P., Abowafia, M., & Shah, J. (2023) · Medicine · doi:10.1097/md.0000000000034503 · Cited by 34
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Krey, L., Huber, M. K., Höglinger, G. U., & Wegner, F. (2021) · Brain Sciences · doi:10.3390/brainsci11121654 · Cited by 31
The Role of Chronic Infection in Alzheimer’s Disease: Instigators, Co-conspirators, or Bystanders?
Butler, L., & Walker, K. A. (2021) · Current Clinical Microbiology Reports · doi:10.1007/s40588-021-00168-6 · Cited by 30
Increased incidence of dementia following herpesvirus infection in the Korean population
Shim, Y., Park, M., & Kim, J. (2022) · Medicine · doi:10.1097/md.0000000000031116 · Cited by 31
The Viral Hypothesis in Alzheimer’s Disease: Novel Insights and Pathogen-Based Biomarkers
Naughton, S. X., Raval, U., & Pasinetti, G. M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030074 · Cited by 30
Tzeng, N., Chung, C., Chang, H., Chang, C.-C., Lu, R., Yeh, H., Chiang, W.-S., Kao, Y., Chang, S., & Chien, W. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7632 · Cited by 29
Self-citationDasriya, V. L., Samtiya, M., Dhewa, T., Puniya, M., Kumar, S., Ranveer, S. A., Chaudhary, V., Vij, S., Behare, P. V., Singh, N., et al. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.14043 · Cited by 29
The A-to-Z factors associated with cognitive impairment. Results of the DeCo study
Gil‐Peinado, M., Alacreu, M., Ramos, H., Sendra‐Lillo, J., García-García, C., García‐Lluch, G., de Coca, T. L., Sala‐Climent, M., & Moreno, L. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1152527 · Cited by 29
Moné, Y., Earl, J. P., Król, J. E., Ahmed, A., Sen, B., Ehrlich, G. D., & Lapides, J. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1123228 · Cited by 29
Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer’s Disease
Liu, C., & Yu, J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00297 · Cited by 27
Gauthier, S. G., Aisen, P. S. S., Cummings, J. L., Detke, M. J., Longo, F. M., Raman, R., Sabbagh, M. N., Schneider, L. S., Tanzi, R. E., Tariot, P. N., et al. (2020) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.18 · Cited by 29
Clark, I., & Vissel, B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201186 · Cited by 27
Herpesvirus Infections and Risk of Parkinson’s Disease
Camacho‐Soto, A., Faust, I. M., Racette, B. A., Clifford, D. B., Checkoway, H., & Nielsen, S. S. (2020) · Neurodegenerative Diseases · doi:10.1159/000512874 · Cited by 27
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
Fülöp, T., Tripathi, S., Rodrigues, S., Desroches, M., Bunt, T., Eiser, A. R., Bernier, F., Beauregard, P. B., Barron, A. E., Khalil, A., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264910 · Cited by 27
Dochnal, S. A., Merchant, H. Y., Schinlever, A. R., Babnis, A. W., Depledge, D. P., Wilson, A. C., & Cliffe, A. R. (2022) · Journal of Virology · doi:10.1128/jvi.00508-22 · Cited by 21
Viruses and amyloids - a vicious liaison
Hammarström, P., & Nyström, S. (2023) · Prion · doi:10.1080/19336896.2023.2194212 · Cited by 29
Liu, Y., Johnston, C., Jarousse, N., Fletcher, S. P., & Iqbal, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093946 · Cited by 32
Qin, Q., & Li, Y. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25481 · Cited by 26
Yang, H.-Y., Chien, W., Chung, C., Su, R., Lai, C., Yang, C.-C., & Tzeng, N. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04928-7 · Cited by 26
Self-citationAntiherpetic drugs: a potential way to prevent Alzheimer’s disease?
Linard, M., Bezin, J., Hucteau, E., Joly, P., Garrigue, I., Dartigues, J., Pariente, A., & Helmer, C. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00950-0 · Cited by 26
Increased risk of dementia in patients with genital warts: A nationwide cohort study in Taiwan
Lin, C., Chien, W., Chung, C., Chiang, C., Wang, W., Chang, H., Kao, Y., & Tzeng, N. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15277 · Cited by 26
Self-citationMekli, K., Lophatananon, A., Cant, R., Burns, A., Dobson, C. B., Itzhaki, R. F., & Muir, K. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0274872 · Cited by 25
Aravindraja, C., Ravi, S., Liu, X., Goodwin, M. S., Veena, P., Godovikova, V., Fenno, J. C., Levites, Y., Golde, T. E., & Kesavalu, L. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063328 · Cited by 26
Duggan, M. R., Peng, Z., An, Y., Kitner Triolo, M. H., Shafer, A. T., Davatzikos, C., Erus, G., Karikkineth, A., Lewis, A., Moghekar, A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201036 · Cited by 24
The Association Between Anemia of Chronic Inflammation and Alzheimer’s Disease and Related Dementias
Andreev, A., Erdinc, B., Shivaraj, K., Schmutz, J.-L., Levochkina, O., Bhowmik, D., Farag, F., Money, K. M., Primavera, L. H., Gotlieb, V. K., et al. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200178 · Cited by 25
The elusive role of herpesviruses in Alzheimer’s disease: current evidence and future directions
Piotrowski, S. L., Tucker, A., & Jacobson, S. (2023) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0011 · Cited by 24
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease
Devanand, D. P., Wısnıewskı, T., Razlighi, Q. R., Qian, M., Wei, R., Andrews, H., Acosta, E. P., Bell, K. L., Pelton, G. H., Deliyannides, D. A., et al. (2025) · JAMA · doi:10.1001/jama.2025.21738 · Cited by 27
A Perspective on Roles Played by Immunosenescence in the Pathobiology of Alzheimer's Disease
Zhao, Y. G., Zhan, J., & Liu, Y. (2020) · Aging and Disease · doi:10.14336/ad.2020.0205 · Cited by 23
Zilli, E. M., O’Donnell, A., Salinas, J., Aparicio, H. J., Gonzales, M. M., Jacob, M. E., Beiser, A., & Seshadri, S. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200957 · Cited by 25
Hemmingsson, E., Hjelmare, E., Weidung, B., Olsson, J., Josefsson, M., Adolfsson, R., Nyberg, L. H., Elgh, F., & Lövheim, H. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12187 · Cited by 22
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 22
Risk of Psychiatric Disorders in Overactive Bladder Syndrome: A Nationwide Cohort Study in Taiwan
Tzeng, N., Chang, H., Chung, C., Kao, Y., Yeh, H., Yeh, C., Chiang, W.-S., Huang, S., Lu, R., & Chien, W. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000835 · Cited by 23
Self-citationAraya, K., Watson, R., Khanipov, K., Golovko, G., & Taglialatela, G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251317228 · Cited by 22
PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer’s disease risk
Lindman, K. L., Jonsson, C., Weidung, B., Olsson, J., Pandey, J. P., Prokopenko, D., Tanzi, R. E., Hallmans, G., Eriksson, S., Elgh, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17058-6 · Cited by 24
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau
Mody, P. H., Marvin, K. N., Hynds, D. L., & Hanson, L. K. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-022-01109-9 · Cited by 22
Peripheral inflammation is a potential etiological factor in Alzheimer’s disease
Li, Z., Wang, H., & Yin, Y. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0049 · Cited by 23
Zhao, M., Ma, G., Yan, X., Li, X., Wang, E., Xu, X.-X., Zhao, J.-B., Ma, X., & Zeng, J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02428-5 · Cited by 21
Do microbes play a role in Alzheimer's disease?
Williams, Z. A. P., Láng, L., Nicolas, S., Clarke, G. A., Cryan, J. F., Vauzour, D., & Nolan, Y. M. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14462 · Cited by 21
Lindman, K. L., Weidung, B., Olsson, J., Josefsson, M., Johansson, A. S., Eriksson, S., Hallmans, G., Elgh, F., & Lövheim, H. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210008 · Cited by 21
Wang, Y., Song, X., Wang, Y., Huang, L., Luo, W., Li, F., Qin, S., Wang, Y., Xiao, J., Wu, Y., et al. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1794789 · Cited by 23
Self-citationBaggiani, M., Dell’Anno, M. T., Pistello, M., Conti, L., & Onorati, M. (2020) · Cells · doi:10.3390/cells9081893 · Cited by 20
Athanasiou, E., Gargalionis, A. N., Anastassopoulou, C. G., Tsakris, A., & Boufidou, F. (2022) · Brain Sciences · doi:10.3390/brainsci12081010 · Cited by 20
Systemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
Bathini, P., Dupanloup, I., Zenaro, E., Terrabuio, E., Fischer, A., Ballabani, E., Doucey, M., & Alberi, L. A. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100568 · Cited by 22
Benyumiza, D., Kumakech, E., Gutu, J., Banihani, J., Mandap, J., Talib, Z. M., Wakida, E. K., Maling, S., & Obua, C. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04174-9 · Cited by 20
Francesco, M. A. D. (2024) · Viruses · doi:10.3390/v16010133 · Cited by 22
Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?
Zhang, S., Lu, J., Jin, Z., Xu, H., Zhang, D., Chen, J., & Wang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1459655 · Cited by 25
Pandey, J. P., Olsson, J., Weidung, B., Kothera, R. T., Johansson, A. S., Eriksson, S., Hallmans, G., Elgh, F., & Lövheim, H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000351 · Cited by 20
Whitford, A. L., Clinton, C. A., Kennedy, E. B. L., Dochnal, S. A., Suzich, J. B., & Cliffe, A. R. (2022) · Journal of Virology · doi:10.1128/jvi.00475-22 · Cited by 16
The Viral Protein Corona Directs Viral Pathogenesis and Amyloid AggregationPreprint
Ezzat, K., Pernemalm, M., Pålsson, S. A., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/246785 · Cited by 20
Readhead, B., Mastroeni, D., Wang, Q., Sierra, M. A., de Ávila, C., Jimoh, T. O., Haure‐Mirande, J., Atanasoff, K. E., Nolz, J., Suazo, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14401 · Cited by 23
Analysis of ALS-related proteins during herpes simplex virus-2 latent infection
Cabrera, J. R., Rodríguez‐Izquierdo, I., Jiménez, J. L., & Muñoz‐Fernández, M. Á. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02044-4 · Cited by 19
Elkind, M. S. V., Moon, M. P., Rundek, T., Wright, C. B., Cheung, K., Sacco, R. L., & Hornig, M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.011 · Cited by 18
Bocharova, O. V., Fisher, A., Pandit, N. P., Molesworth, K., Mychko, O., Scott, A. J., Makarava, N., Ritzel, R., & Baskakov, I. V. (2023) · Brain Pathology · doi:10.1111/bpa.13116 · Cited by 16
Wennberg, A. M., Maher, B. S., Rabinowitz, J. A., Holingue, C., Felder, W. R., Wells, J. L., Munro, C. A., Lyketsos, C. G., Eaton, W. W., Walker, K. A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13070 · Cited by 19
Gao, J., Feng, L., Wu, B., Xia, W., Xie, P., Ma, S., Liu, H., Meng, M., & Sun, Y. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07038-7 · Cited by 19
From defense to disease: IFITM3 in immunity and Alzheimer's disease
Kehs, Z., Cross, A. C., & Li, Y. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00482 · Cited by 21
Yang, C.-C., Chien, W., Chung, C., Liu, Y., Yeh, C., Chen, K.-H., Yang, S., Chang, H., Kao, Y., Lu, W.-C., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225584 · Cited by 18
Self-citationSymptomatic Herpes Simplex Virus Infection and Risk of Dementia in US Veterans: a Cohort Study
Young‐Xu, Y., Powell, E. I., Zwain, G., Yazdi, M. T., Gui, J., & Shiner, B. R. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01084-9 · Cited by 18
Pharmacists’ Knowledge of Factors Associated with Dementia: The A-to-Z Dementia Knowledge List
Ramos, H., Moreno, L., Gil‐Peinado, M., García‐Lluch, G., Sendra‐Lillo, J., & Alacreu, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18199934 · Cited by 18
Liu, R.-Y., Yin, K., He, S., Su, W., Duan, Q., Wen, X.-J., Chen, T., Shen, C., Li, J.-R., Cao, B., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03639-2 · Cited by 17
Xu, Y., Zheng, F., Zhong, Q., & Zhu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230002 · Cited by 20
Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review
Farrer, T. J., Moore, J. D., Chase, M., Gale, S. D., & Hedges, D. W. (2024) · Pathogens · doi:10.3390/pathogens13110974 · Cited by 17
From conifers to cognition: Microbes, brain and behavior
Lathe, R., & Clair, D. S. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12680 · Cited by 16
Ijezie, E. C., Miller, M. J., Hardy, C., Jarvis, A. R., Czajka, T. F., D’Brant, L., Rugenstein, N., Waickman, A. T., Murphy, E. A., & Butler, D. C. (2025) · Brain Pathology · doi:10.1111/bpa.70006 · Cited by 20
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16
A review of the roles of pathogens in Alzheimer’s disease
Zhao, M., Wang, Y., Shen, Y., Wei, C., Zhang, G., & Sun, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1439055 · Cited by 18
Lindblom, N., Lindquist, L., Westman, J., Åström, M., Bullock, R. A., Hendrix, S. B., & Wahlund, L. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210301 · Cited by 15
Zhou, X., Kumar, P., Bhuyan, D. J., Jensen, S. O., Roberts, T. L., & Münch, G. W. (2023) · Biomolecules · doi:10.3390/biom13111568 · Cited by 17
Herpesviruses, antiviral treatment, and the risk of dementia – systematic review and meta-analysis
Drinkall, N. J., Siersma, V., Lathe, R., Waldemar, G., & Janbek, J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01838-z · Cited by 14
Shi, R., Yu, S., Larbi, A., Ng, T. P., & Lu, Y. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.026 · Cited by 14
Microglia in Neurodegenerative Diseases
Awogbindin, I. O., Wanklin, M., Verkhratsky, A., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_27 · Cited by 14
Blandi, L., Bertuccio, P., Signorelli, C., Brand, H., Clemens, T., Renzi, C., & Odone, A. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100167 · Cited by 14
LAMP2 deficiency attenuates the neurodegeneration markers induced by HSV-1 infection
Kristen, H., Sastre, I., Aljama, S., Fuentes, M., Recuero, M., Frank, A., Martín, Á. G., Sánchez‐Juan, P., Lage, C., Bullido, M. J., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105032 · Cited by 14
Bigley, T. M., Xiong, M., Ali, M., Chen, Y., Wang, C., Serrano, J. R., Eteleeb, A. M., Harari, O., Yang, L., Patel, S. J., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00514-8 · Cited by 15
COVID-19 and Alzheimer’s Disease: What Is the Connection?
Itzhaki, R. F. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220955 · Cited by 14
Pinworm infections associated with risk of psychiatric disorders-A nationwide cohort study in Taiwan
Chao, P.-C., Chien, W., Chung, C., Chu, C., Yeh, C., Chang, H., Kao, Y., Yeh, H., Chiang, W.-S., & Tzeng, N. (2019) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.02.002 · Cited by 14
Self-citationPotential Role for Herpesviruses in Alzheimer’s Disease
Duggan, M. R., Torkzaban, B., Ahooyi, T. M., & Khalili, K. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200814 · Cited by 13
Lin, Y., Yoo, J. M., Li, D., Heo, Y., Okumura, M., Won, H., Vendruscolo, M., Lim, M. H., & Lee, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00507-3 · Cited by 16
Dementia and cognitive impairment in adults as sequels of HSV-1-related encephalitis: a review
Campos, E. M. N., Rodrigues, L. D., Oliveira, L. F., & dos Santos, J. C. C. (2021) · Dementia & Neuropsychologia · doi:10.1590/1980-57642021dn15-020002 · Cited by 15
Alzheimer's disease and herpes viruses: Current events and perspectives
Pinchera, B., Filippo, I. D., Cuccurullo, F., Salvatore, E., & Gentile, I. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2550 · Cited by 17
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Bathini, P., Brai, E., Balin, B. J., Bimler, L. H., Corry, D. B., Devanand, D. P., Doty, R. L., Ehrlich, G. D., Eimer, W. A., Fülöp, T., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae328 · Cited by 14
A Lipid-Raft Theory of Alzheimer's Disease
Rappoport, A. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052024-115455 · Cited by 15
Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
Norins, L. C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210080 · Cited by 13
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine
Hulce, K. R., Jaishankar, P., Lee, G., Bohn, M., Connelly, E. J., Wucherer, K., Ongpipattanakul, C., Volk, R. F., Chuo, S., Arkin, M. R., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.03.007 · Cited by 13
Boukhvalova, M. S., Kastrukoff, L. F., & Blanco, J. C. G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1204852 · Cited by 11
Shi, M., Li, C., Tian, X., Chu, F., & Zhu, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.685863 · Cited by 13
Does Dementia Have a Microbial Cause?
Landry, R. L., & Embers, M. E. (2022) · NeuroSci · doi:10.3390/neurosci3020019 · Cited by 14
Warren‐Gash, C., Cadogan, S. L., Nicholas, J. M., Breuer, J. M., Shah, D., Pearce, N., Shiekh, S., Smeeth, L., Farlow, M. R., Mori, H., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51669 · Cited by 11
Weinmann, S. A., Rawlings, A. M., Koppolu, P., Rosales, A. G., Prado, Y. K., & Schmidt, M. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296957 · Cited by 11
Chen, D. T.-L., Chang, J. P., Cheng, S., Chang, H.-C., Hsu, J., Chang, H., Chiu, W., & Su, K. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.017 · Cited by 10
Self-citationSong, X., Wang, Y., Li, F., Cao, W., Zeng, Q., Qin, S., Wang, Z., Jia, J., Xiao, J., Hu, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.799890 · Cited by 11
Sun, X., Zhang, H., Yao, D., Xu, Y., Jing, Q., Cao, S., Li, T., & Li, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215232 · Cited by 12
Herpes simplex virus infection and the risk of dementia: a systematic review and meta-analysis
Elhalag, R. H., Motawea, K. R., Talat, N. E., Rouzan, S. S., Mahmoud, N., Hammad, E. M., Reyad, S. M., Mohamed, M., & Shah, J. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000951 · Cited by 11
Wang, T.-M., Lee, Y., Chung, C., Sun, C., Kang, C.-Y., Wu, G., & Chien, W. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s430252 · Cited by 10
Self-citationThapa, S., Shah, S., Bhattarai, A., Panah, M. Y., Chand, S., & Mirmosayyeb, O. (2024) · Health Science Reports · doi:10.1002/hsr2.1941 · Cited by 10
Brendborg, N., & Febbraio, M. A. (2025) · The Journal of Physiology · doi:10.1113/jp286747 · Cited by 10
Metadata
- Authors
- Tzeng, N.-S., Chung, C.-H., Lin, F.-H., Chiang, C.-P., Yeh, C.-B., Huang, S.-Y., Lu, R.-B., Chang, H.-A., Kao, Y.-C., Yeh, H.-W., Chiang, W.-S., Chou, Y.-C., Tsao, C.-H., Wu, Y.-F., & Chien, W.-C.
- Affiliations
- Tri-Service General Hospital (TW)
- National Defense Medical Center (TW)
- Tamkang University (TW)
- Corresponding author
- Chien, Wu-Chien
- ORCID
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 15
- Issue
- 2
- Pages
- 417-429
- ISSN
- 1878-7479 (ISSN-L)
- PMC
- PMC5935641
- OpenAlex
- W2790037954
- Cited by
- 356
- References
- 67
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 41 · 2023: 40 · 2022: 49 · 2021: 59 · 2020: 48 · 2019: 29 · 2018: 21
- FWCI
- 30.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neurotherapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tri-Service General Hospital Research Foundation (TSGH-C105-130, TSGH-C106-002, TSGH-C107-004)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- herpes simplex, dementia risk, antiviral therapy, neurodegeneration, Taiwan
- MeSH terms
- Aged, Antiviral Agents, Dementia, Female, Herpes Simplex, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Taiwan, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review